These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35460142)
1. International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID-19 pandemic: A cross-sectional analysis of 66 countries. Gomes T; Kim KC; Suda KJ; Garg R; Tadrous M Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):779-787. PubMed ID: 35460142 [TBL] [Abstract][Full Text] [Related]
2. Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study. Callaway Kim K; Tadrous M; Kane-Gill SL; Barbash IJ; Rothenberger SD; Suda KJ Chest; 2021 Dec; 160(6):2123-2134. PubMed ID: 34389295 [TBL] [Abstract][Full Text] [Related]
3. The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis. Suda KJ; Kim KC; Hernandez I; Gellad WF; Rothenberger S; Campbell A; Malliart L; Tadrous M J Am Pharm Assoc (2003); 2022; 62(3):766-774.e6. PubMed ID: 35094929 [TBL] [Abstract][Full Text] [Related]
4. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic. Currie JM; Schnell MK; Schwandt H; Zhang J JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474 [TBL] [Abstract][Full Text] [Related]
5. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect. Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965 [TBL] [Abstract][Full Text] [Related]
6. Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis. Zeitouny S; Suda KJ; Mitsantisuk K; Law MR; Tadrous M BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34857523 [TBL] [Abstract][Full Text] [Related]
7. Alcohol consumption and closed borders - how COVID-19 restrictions have impacted alcohol sales and consumption in Europe. Leifman H; Dramstad K; Juslin E BMC Public Health; 2022 Apr; 22(1):692. PubMed ID: 35395783 [TBL] [Abstract][Full Text] [Related]
8. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence. Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466 [TBL] [Abstract][Full Text] [Related]
9. Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013-2019: A Retrospective Observational Study. Richards GC; Aronson JK; MacKenna B; Goldacre B; Hobbs FDR; Heneghan C Drug Saf; 2022 Mar; 45(3):237-247. PubMed ID: 35066803 [TBL] [Abstract][Full Text] [Related]
10. The impact of the COVID-19 pandemic on community prescription of opioid and antineuropathic analgesics for cancer patients in Wales, UK. Han J; Rolles M; Torabi F; Griffiths R; Bedston S; Akbari A; Burnett B; Lyons J; Greene G; Thomas R; Long T; Arnold C; Huws DW; Lawler M; Lyons RA Support Care Cancer; 2023 Aug; 31(9):531. PubMed ID: 37606853 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study. Jung M; Lukose D; Nielsen S; Bell JS; Webb GI; Ilomäki J Br J Clin Pharmacol; 2023 Feb; 89(2):914-920. PubMed ID: 36301837 [TBL] [Abstract][Full Text] [Related]
12. Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19). Khouja T; Mitsantisuk K; Tadrous M; Suda KJ J Antimicrob Chemother; 2022 Apr; 77(5):1491-1499. PubMed ID: 35178565 [TBL] [Abstract][Full Text] [Related]
13. Temporal Trends in Opioid Prescribing Practices in Children, Adolescents, and Younger Adults in the US From 2006 to 2018. Renny MH; Yin HS; Jent V; Hadland SE; Cerdá M JAMA Pediatr; 2021 Oct; 175(10):1043-1052. PubMed ID: 34180978 [TBL] [Abstract][Full Text] [Related]
14. Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study. Aboulatta L; Peymani P; Vaccaro C; Leong C; Kowalec K; Delaney J; Falk J; Alessi-Severini S; Aloud B; Eltonsy S PLoS One; 2022; 17(11):e0278072. PubMed ID: 36441676 [TBL] [Abstract][Full Text] [Related]
15. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017. Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783 [TBL] [Abstract][Full Text] [Related]
16. Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. Clement J; Jacobi M; Greenwood BN PLoS One; 2021; 16(4):e0249453. PubMed ID: 33793663 [TBL] [Abstract][Full Text] [Related]
17. Changes in Quantity of Opioids Dispensed following Florida's Restriction Law for Acute Pain Prescriptions. Hincapie-Castillo JM; Easey T; Hernandez C; Maguire M; Usmani SA; Vouri SM; Goodin A Pain Med; 2021 Aug; 22(8):1870-1876. PubMed ID: 33502536 [TBL] [Abstract][Full Text] [Related]
18. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis. Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994 [TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Downs CG; Varisco TJ; Bapat SS; Shen C; Thornton JD Res Social Adm Pharm; 2021 Jan; 17(1):2005-2008. PubMed ID: 33317769 [TBL] [Abstract][Full Text] [Related]
20. Opioid epidemics during the pandemic: Further insights to the same story. Ayad AE J Opioid Manag; 2021; 17(1):9-12. PubMed ID: 33735423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]